期刊
CLINICAL AND VACCINE IMMUNOLOGY
卷 16, 期 2, 页码 285-287出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/CVI.00363-08
关键词
-
资金
- Pediatric Dengue Vaccine Initiative of the International Vaccine Institute [TR 03/04, TR16]
Sera from patients involved in a Peruvian outbreak of dengue virus serotype 1 infection cross-neutralized the American genotype of dengue virus serotype 2 up to 100-fold more efficiently than they did the virulent Asian genotype of dengue virus serotype 2, as determined by a plaque reduction neutralization test (PRNT) with CV-1 fibroblasts modified to express human Fc gamma receptor CD32. The concordant preferential immune enhancement of the Asian genotype of dengue virus serotype 2 in human monocytes suggests that such a modification might strengthen the correlation between the PRNT titer and protection.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据